Ocular Therapeutix, Inc.
(OCUL - NASDAQ)
9,52 USD
📋 Profilo Aziendale

Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology.

|